Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physostigmine for Delirium in Perioperative Intensive Care
NCT02216266Phase 3Unknown
- Start
- Apr 2014
- Primary completion
- Dec 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of physostigmine in delirium. Status: unknown.
02
Drugs
physostigmine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02216266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216266.